Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer

Jong Ha Hwang, Seung Hun Song, Jae Kwan Lee, Nak Woo Lee, Kyu Wan Lee

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: The aim of this study was to examine the bone mineral density (BMD) of women with cervical cancer treated with chemoradiation and to compare the outcomes with those of women with myomas treated by hysterectomy. Methods: The BMDs of 43 women with cervical cancer treated with concurrent chemoradiation (CCRT) were measured by dual-energy X-ray absorptiometry (L-spine and proximal femur) and compared with those of 43 matched control women with the same age distribution and body mass index. Medical records were reviewed retrospectively. Both women with cervical cancer and control women had reached menopause or had a history of bilateral salpingo-oophorectomy. Results: The lowest T scores for BMD were significantly lower in the women with cervical cancer treated with CCRT compared with the control women (P = 0.017). The serum total alkaline phosphatase was significantly higher in women with cervical cancer treated with CCRT (P = 0.027). There was no correlation between total alkaline phosphatase and BMD (L-spine and proximal femur; r = 0.089, P = 0.416). The BMDs of both the greater trochanter of the femur (P = 0.013) and L4 (P = 0.011) were significantly lower in women with cervical cancer than in the control women. Conclusions: The results of this study suggest that postmenopausal women with uterine cervical cancer treated with CCRT have a lower BMD and are at risk for osteoporosis.

Original languageEnglish
Pages (from-to)416-420
Number of pages5
JournalMenopause
Volume17
Issue number2
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

Uterine Cervical Neoplasms
Bone Density
Femur
Alkaline Phosphatase
Spine
Myoma
Age Distribution
Photon Absorptiometry
Ovariectomy
Menopause
Hysterectomy
Osteoporosis
Medical Records
Body Mass Index

Keywords

  • Bone mineral density
  • Cervical cancer
  • Concurrent chemoradiation
  • Menopause

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer. / Hwang, Jong Ha; Song, Seung Hun; Lee, Jae Kwan; Lee, Nak Woo; Lee, Kyu Wan.

In: Menopause, Vol. 17, No. 2, 01.03.2010, p. 416-420.

Research output: Contribution to journalArticle

Hwang, Jong Ha ; Song, Seung Hun ; Lee, Jae Kwan ; Lee, Nak Woo ; Lee, Kyu Wan. / Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer. In: Menopause. 2010 ; Vol. 17, No. 2. pp. 416-420.
@article{4aac5b2412b6416195ee36fbb415255d,
title = "Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer",
abstract = "Objective: The aim of this study was to examine the bone mineral density (BMD) of women with cervical cancer treated with chemoradiation and to compare the outcomes with those of women with myomas treated by hysterectomy. Methods: The BMDs of 43 women with cervical cancer treated with concurrent chemoradiation (CCRT) were measured by dual-energy X-ray absorptiometry (L-spine and proximal femur) and compared with those of 43 matched control women with the same age distribution and body mass index. Medical records were reviewed retrospectively. Both women with cervical cancer and control women had reached menopause or had a history of bilateral salpingo-oophorectomy. Results: The lowest T scores for BMD were significantly lower in the women with cervical cancer treated with CCRT compared with the control women (P = 0.017). The serum total alkaline phosphatase was significantly higher in women with cervical cancer treated with CCRT (P = 0.027). There was no correlation between total alkaline phosphatase and BMD (L-spine and proximal femur; r = 0.089, P = 0.416). The BMDs of both the greater trochanter of the femur (P = 0.013) and L4 (P = 0.011) were significantly lower in women with cervical cancer than in the control women. Conclusions: The results of this study suggest that postmenopausal women with uterine cervical cancer treated with CCRT have a lower BMD and are at risk for osteoporosis.",
keywords = "Bone mineral density, Cervical cancer, Concurrent chemoradiation, Menopause",
author = "Hwang, {Jong Ha} and Song, {Seung Hun} and Lee, {Jae Kwan} and Lee, {Nak Woo} and Lee, {Kyu Wan}",
year = "2010",
month = "3",
day = "1",
doi = "10.1097/gme.0b013e3181b9b11f",
language = "English",
volume = "17",
pages = "416--420",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer

AU - Hwang, Jong Ha

AU - Song, Seung Hun

AU - Lee, Jae Kwan

AU - Lee, Nak Woo

AU - Lee, Kyu Wan

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Objective: The aim of this study was to examine the bone mineral density (BMD) of women with cervical cancer treated with chemoradiation and to compare the outcomes with those of women with myomas treated by hysterectomy. Methods: The BMDs of 43 women with cervical cancer treated with concurrent chemoradiation (CCRT) were measured by dual-energy X-ray absorptiometry (L-spine and proximal femur) and compared with those of 43 matched control women with the same age distribution and body mass index. Medical records were reviewed retrospectively. Both women with cervical cancer and control women had reached menopause or had a history of bilateral salpingo-oophorectomy. Results: The lowest T scores for BMD were significantly lower in the women with cervical cancer treated with CCRT compared with the control women (P = 0.017). The serum total alkaline phosphatase was significantly higher in women with cervical cancer treated with CCRT (P = 0.027). There was no correlation between total alkaline phosphatase and BMD (L-spine and proximal femur; r = 0.089, P = 0.416). The BMDs of both the greater trochanter of the femur (P = 0.013) and L4 (P = 0.011) were significantly lower in women with cervical cancer than in the control women. Conclusions: The results of this study suggest that postmenopausal women with uterine cervical cancer treated with CCRT have a lower BMD and are at risk for osteoporosis.

AB - Objective: The aim of this study was to examine the bone mineral density (BMD) of women with cervical cancer treated with chemoradiation and to compare the outcomes with those of women with myomas treated by hysterectomy. Methods: The BMDs of 43 women with cervical cancer treated with concurrent chemoradiation (CCRT) were measured by dual-energy X-ray absorptiometry (L-spine and proximal femur) and compared with those of 43 matched control women with the same age distribution and body mass index. Medical records were reviewed retrospectively. Both women with cervical cancer and control women had reached menopause or had a history of bilateral salpingo-oophorectomy. Results: The lowest T scores for BMD were significantly lower in the women with cervical cancer treated with CCRT compared with the control women (P = 0.017). The serum total alkaline phosphatase was significantly higher in women with cervical cancer treated with CCRT (P = 0.027). There was no correlation between total alkaline phosphatase and BMD (L-spine and proximal femur; r = 0.089, P = 0.416). The BMDs of both the greater trochanter of the femur (P = 0.013) and L4 (P = 0.011) were significantly lower in women with cervical cancer than in the control women. Conclusions: The results of this study suggest that postmenopausal women with uterine cervical cancer treated with CCRT have a lower BMD and are at risk for osteoporosis.

KW - Bone mineral density

KW - Cervical cancer

KW - Concurrent chemoradiation

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=77949376791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949376791&partnerID=8YFLogxK

U2 - 10.1097/gme.0b013e3181b9b11f

DO - 10.1097/gme.0b013e3181b9b11f

M3 - Article

VL - 17

SP - 416

EP - 420

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 2

ER -